**Question:** Hyperkinetic syndromes such as chorea and athetosis are usually associated with pathological changes in which part of the brain?

**Core Concept:** Hyperkinetic syndromes are a group of movement disorders characterized by excessive and irregular involuntary movements, typically affecting the limbs and face. Chorea and athetosis are two examples of hyperkinetic syndromes.

**Why the Correct Answer is Right:**

Hyperkinetic syndromes are primarily due to dysfunction in the basal ganglia, a group of nuclei located deep in the brain's cerebral hemispheres. These nuclei play a crucial role in regulating voluntary motor control and are involved in the pathophysiology of hyperkinetic syndromes.

**Why Each Wrong Option is Incorrect:**

A. Pathological changes in the cerebellum: While the cerebellum is involved in motor control, it is not primarily responsible for hyperkinetic syndromes.
B. Pathological changes in the cerebral cortex: The cerebral cortex is involved in higher cognitive functions and sensory processing, not motor control or hyperkinetic syndromes.
C. Pathological changes in the brainstem: Although the brainstem is involved in motor control, it is not the primary location for hyperkinetic syndromes.
D. Pathological changes in the cerebral hemispheres: The cerebral hemispheres are involved in various cognitive functions, not specifically motor control or hyperkinetic syndromes.

**Clinical Pearl / High-Yield Fact:**

The basal ganglia play a critical role in motor control and are particularly vulnerable to pathological changes due to their high energy requirements and limited compensatory mechanisms. When the basal ganglia become dysfunctional, it can lead to hyperkinetic syndromes like chorea and athetosis.

**Correct Answer:** D. Pathological changes in the cerebral hemispheres

Understanding the location of pathological changes in these syndromes is important for making an accurate diagnosis and appropriate treatment decisions. In conclusion, hyperkinetic syndromes are primarily associated with pathological changes in the cerebral hemispheres, specifically affecting the motor control pathways. This helps in differentiating them from other movement disorders and guiding clinical decision-making.